Managing Raynaud's phenomenon.
作者信息
Roath S
出版信息
Br Med J (Clin Res Ed). 1986 Jul 12;293(6539):88-9. doi: 10.1136/bmj.293.6539.88.
Abstract
摘要
相似文献
1
Managing Raynaud's phenomenon.治疗雷诺现象。
Br Med J (Clin Res Ed). 1986 Jul 12;293(6539):88-9. doi: 10.1136/bmj.293.6539.88.
2
[Raynaud's phenomena: diagnostic and treatment study].[雷诺现象：诊断与治疗研究]
Rev Prat. 1998 Oct 1;48(15):1659-64.
3
[Understanding Raynaud's phenomenon: towards a better treatment].[认识雷诺现象：寻求更好的治疗方法]
Rev Med Suisse. 2006 Jan 11;2(48):93-6.
4
Treatment of Raynaud's phenomenon.雷诺现象的治疗。
Autoimmun Rev. 2008 Oct;8(1):62-8. doi: 10.1016/j.autrev.2008.07.002. Epub 2008 Aug 8.
5
Raynaud's phenomenon.雷诺现象
Curr Opin Rheumatol. 1992 Dec;4(6):825-36.
6
Managing Raynaud's phenomenon: a practical approach.雷诺现象的管理：一种实用方法。
Am Fam Physician. 1993 Mar;47(4):823-9.
7
[Raynaud's phenomenon, disease or syndrome?].[雷诺现象、疾病还是综合征？]
Rev Prat. 2011 Sep;61(7):899-903.
8
ESVM guidelines - the diagnosis and management of Raynaud's phenomenon.欧洲血管医学学会指南——雷诺现象的诊断与管理
Vasa. 2017 Oct;46(6):413-423. doi: 10.1024/0301-1526/a000661. Epub 2017 Sep 12.
9
Raynaud's phenomenon.雷诺现象
Bull Soc Int Chir. 1962 Jan-Feb;21:73-80.
10
Raynaud's phenomenon: pathogenesis and management.雷诺现象：发病机制与治疗
J Am Acad Dermatol. 2008 Oct;59(4):633-53. doi: 10.1016/j.jaad.2008.06.004. Epub 2008 Jul 24.
引用本文的文献
1
Nisoldipine in primary Raynaud's phenomenon.尼索地平治疗原发性雷诺现象。
Eur J Clin Pharmacol. 1987;33(1):27-30. doi: 10.1007/BF00610375.
2
Management of Raynaud's phenomenon. Focus on newer treatments.雷诺现象的管理。聚焦于新型治疗方法。
Drugs. 1989 May;37(5):700-12. doi: 10.2165/00003495-198937050-00005.
3
The effect of isradipine, a new calcium-channel antagonist, in patients with primary Raynaud's phenomenon: a single-blind dose-response study.
Cardiovasc Drugs Ther. 1989 Jun;3(3):397-401. doi: 10.1007/BF01858110.
本文引用的文献
1
The treatment of severe Raynaud's phenomenon with verapamil.用维拉帕米治疗严重雷诺现象。
J Clin Pharmacol. 1982 Jan;22(1):74-6. doi: 10.1002/j.1552-4604.1982.tb05712.x.
2
Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.用酮色林治疗结缔组织病患者的雷诺现象。
Br Med J (Clin Res Ed). 1984 Sep 8;289(6445):577-9. doi: 10.1136/bmj.289.6445.577.
3
Blood viscosity, finger systolic pressure and effect of dazoxiben treatment in primary vasospastic disease.
Ups J Med Sci. 1984;89(3):213-9. doi: 10.3109/03009738409179501.
4
Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.雷尼尔氏综合征患者间歇性输注依前列醇（前列环素）：一项双盲对照试验。
Lancet. 1983 Feb 12;1(8320):313-5. doi: 10.1016/s0140-6736(83)91624-0.
5
Use of biofeedback training in treatment of Raynaud's disease and phenomenon.生物反馈训练在雷诺病及雷诺现象治疗中的应用。
J Rheumatol. 1985 Feb;12(1):90-3.
6
Behavioral treatment of Raynaud's disease: long-term follow-up.
J Consult Clin Psychol. 1985 Feb;53(1):136. doi: 10.1037//0022-006x.53.1.136.
7
Prostaglandin E1 vasospastic disease and thermography.前列腺素E1、血管痉挛性疾病与热成像
Ann Rheum Dis. 1985 Feb;44(2):73-8. doi: 10.1136/ard.44.2.73.
8
Treatment of Raynaud's phenomenon with calcium channel blockers.用钙通道阻滞剂治疗雷诺现象。
Am J Med. 1985 Feb 22;78(2B):39-42. doi: 10.1016/0002-9343(85)90168-8.
9
Topical nitroglycerin ointment in Raynaud's phenomenon.局部用硝酸甘油软膏治疗雷诺现象。
Z Kardiol. 1985 May;74(5):298-302.
10
Effect of dazoxiben, a thromboxane synthetase inhibitor on skin-blood flow following cold challenge in patients with Raynaud's phenomenon.
Eur J Clin Invest. 1985 Feb;15(1):20-3. doi: 10.1111/j.1365-2362.1985.tb00138.x.
Zotero 插件